Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Bullish +75

The Real Reason Intuitive Surgical Keeps Winning: A Cash Machine Hiding in Plain Sight

📈 Intuitive Surgical (ISRG) shares have risen approximately 580% over the past decade, significantly outperforming the S&P 500's 240% growth.

🤖 The company pioneered the surgical robotics market and currently has an installed base of 11,395 da Vinci surgical robots worldwide.

⚡ While robot demand is strong with 431 systems placed in Q1 2026, only 23% of total revenue comes from selling the actual robots.

🔧 The majority of Intuitive Surgical's revenue is generated from parts, instruments, and accessories used during surgery.

📅 Services account for about 15% of the top line, while instruments and accessories comprise a substantial 60%.

🔄 This business model functions like an annuity where selling more robots expands the recurring revenue base from future parts and service needs.

✂️ The volume of surgeries performed increased by 17% in Q1 2026, indicating that demand for procedures exceeds the rate of new robot deployments.

🔧 As robots age and perform more procedures, they require frequent servicing and replacement instruments, driving consistent cash flow.

🏛️ Intuitive Surgical is described as an "Indispensable Monopoly" providing critical technology that competitors like Nvidia rely on indirectly.

💰 The high valuation of the stock reflects a P/E ratio of 58x, suggesting it is primarily suited for aggressive growth investors.

🚫 Despite its strong performance, ISRG was excluded from The Motley Fool's recent top 10 best stocks list released for current buyers.

📉 Comparisons are made to Netflix and Nvidia as past Stock Advisor picks that delivered massive historical returns prior to their inclusion in the index.

⚠️ Investors are advised to look beyond the initial robot sales to understand the true long-term value of the parts and services flywheel.

Bullish Signals
  • Intuitive Surgical's stock has risen approximately 580% over the past decade, significantly outperforming the S&P 500 which rose only 240% in the same period.
  • The company has a massive installed base of 11,395 da Vinci surgical robots currently being used around the world.
  • Demand for the robots is exceptionally strong, with the company placing 431 systems in the first quarter of 2026, up from 367 a year earlier.
  • The total installed base grew by 12% year over year, driven by robust demand for surgeries performed with da Vinci robots which increased 17% year over year in Q1 2026.
  • Parts and accessories represent a massive 60% of the company's top line, while services make up around 15%, creating a highly profitable annuity-like business model.
  • The 'flywheel effect' ensures that as more robots are sold and used, recurring revenue from parts, instruments, and servicing grows indefinitely until the robot reaches end-of-life.
  • The Motley Fool maintains positions in and recommends Intuitive Surgical, including specific options plays like long January 2028 $520 calls.
Risk Factors
  • The stock carries a lofty price-to-earnings ratio of 58x, suggesting the market may be pricing in overly aggressive future growth that could prove unsustainable.
  • Intuitive Surgical was excluded from The Motley Fool Stock Advisor's top 10 stocks for investors to buy now, indicating analysts prefer alternative investment opportunities over ISRG at this time.
  • The company relies heavily on recurring revenue from parts and accessories (60% of business) and services (15%), which creates a high risk of concentration if surgeons switch to competitors or surgical volume declines.
Full Analysis
Shares of Intuitive Surgical (NASDAQ: ISRG) have surged approximately 580% over the past decade, significantly outpacing the S&P 500's 240% gain during the same period. The company, known for its da Vinci surgical robot, operates as an industry pioneer with a substantial installed base of 11,395 systems globally. Despite strong demand and a 17% year-over-year increase in surgeries performed using the robots in the first quarter of 2026—which exceeded the 12% growth in physical unit sales—the article argues that selling the robots themselves is not the primary driver of Intuitive Surgical's immense valuation or cash flow. Instead, only 23% of the company's revenues are derived from direct robot sales, highlighting that investors must look beyond the initial hardware purchase to understand the business model's core mechanics. The true growth engine for Intuitive Surgical lies in its recurring revenue streams from parts and services. Once a da Vinci system is installed, every surgery performed requires the replacement of instruments and accessories, contributing about 60% to the company's top line. Additionally, servicing needs and other support generate approximately 15% of revenues. This creates an annuity-like effect where each new robot sold expands the potential for future recurring revenue until the system is decommissioned. The more surgeries conducted with da Vinci technology, the higher the volume of consumables needed, and as the scope of procedures supported by the robots grows, so too does the variety of accessories required to perform them. While Intuitive Surgical maintains a high price-to-earnings ratio of 58x, the article positions it as a powerful cash-generating machine driven by this "parts and services flywheel" rather than one-time hardware sales. The text notes that the company was not included in the Motley Fool Stock Advisor's list of ten best stocks to buy now for 2026, which instead featured companies like Netflix and Nvidia, though it acknowledges the Motley Fool holds positions in Intuitive Surgical and has recommended specific options on the stock. The underlying thesis remains that the long-term investment case depends on the expanding ecosystem of consumables and services attached to the growing installed base of surgical robots.